Cell isolation is a method of extraction of the specified cell inside the heterogeneous mixture to develop novel therapies. The global cell isolation market is growing at a significant rate, due to a mounting emphasis on personalized medicine and mounting government funding for cell-based research.
A different product such as consumables and instruments contributed to the cell isolation market size. The market has witnessed a high demand for consumables due to mounting funds by companies to develop advanced products, escalating number of regulatory approvals, and expanding government initiatives for improving cell-based research.
Insight by Product
On the basis of product, the market is subdivided into consumables and instruments. Of all products, consumables segment accounted the larger share in the market, due to mounting funds by companies to develop advanced products, escalating number of regulatory approvals, and expanding government initiatives for improving cell-based research.
The consumables are further subdivided into beads, reagents, kits, media, and sera, and disposables. The instruments are further subdivided into magnetic-activated cell separator systems, centrifuges, filtration systems, and flow cytometers.
Insight by Cell Type
On the basis of cell type, the market is subdivided into human cells and animal cells. Of both the cell type, the human cells accounted foremost share in the cell isolation market, due to technological advancements, extensive usage of isolated differentiated human cells in therapeutic, research, academics, and biopharmaceutical & biotechnology industries and mounting emphasis on human stem cell isolation. The human cell is further subdivided into stem cells and differentiated cells.
Insight by Technique
The different techniques of the market are centrifugation-based cell isolation, filtration-based cell isolation, and surface marker-based cell isolation. Among all techniques, the centrifugation-based cell isolation the largest share in the cell isolation market due to extensive use of this technique for manufacturing antibodies, vaccines, and enzymes, and low cost of centrifugation technique.
Insight by Application
On the basis of application, the market is subdivided into biomolecule isolation, stem cell research, therapeutics, tissue regeneration, cancer research, and in vitro diagnostics. Among all applications, the biomolecule isolation application is expected to grow at the fastest rate in the cell isolation market due to mounting company funds to develop novel biopharmaceutical products.
Insight by End User
The different end users of the market are research laboratories and institutes, cell banks, hospitals, and diagnostic laboratories, and biotechnology and biopharmaceutical companies. Among all end users, the hospitals and diagnostic laboratories are expected to grow at the fastest rate in the cell isolation market, due to the mounting occurrence of viral and bacterial infections.
Mounting government funding for cell-based research, technological advancements, escalating biotechnology and biopharmaceutical industries, expanding the need for biopharmaceuticals, and mounting emphasis on personalized medicine are the primary growth drivers for cell isolation market.
Promoting stem cell research, the mounting occurrence of infectious diseases, and cancer, and the development of microfluidics are also facilitating the growth of the cell isolation market.
Elevated price of cell isolation instruments, difficulties associated with reagent development, and ethical issues associated with embryonic stem cell isolation are the major challenges for the growth of cell isolation market.
Globally, the manufacturing companies trying to enter the cell isolation market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest cell isolation market as in the region the mounting occurrence of infectious diseases and cancer. In addition, technological advancements, and escalating biotechnology and biopharmaceutical industries are also up surging growth of the North American cell isolation market.
Asia-Pacific is observed to witness the fastest growth in the market, due to the mounting occurrence of cancer and infectious diseases. In addition, escalating government support, advanced healthcare infrastructure and mounting emphasis on personalized medicine are also creating a positive impact on the cell isolation market growth in the region.
Key players in the cell isolation market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In August 2016, GE Healthcare signed an agreement with STEMCELL Technologies Inc. to provide T-Cell reagents for commercial-scale cell therapy production, and expands its cell therapy portfolio. Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, Miltenyi Biotec, Terumo Corporation, General Electric Company, Stemcell Technologies Inc., Merck KGaA, and Pluriselect Life Science are the key players offering cell isolation.